Curative has raised 150 million in fresh Series B funding. The raise confirms the companys unicorn status at a valuation of 1.275 billion. The company said the investment will accelerate its plan to redesign the structure of employer health insurance in the United States.
Curative has positioned itself as an alternative to the traditional BUCA insurers. It has built a health plan that removes financial barriers for members. It uses a 0-out-of-pocket model. Members only need to complete one annual preventative appointment called the Baseline Visit.
The company said its model has already produced clear results. Primary care engagement has increased by 20. Hospitalisations have fallen by 30. Drug costs have dropped by up to 40. Curative believes these changes stem from preventative care and early intervention.
